Thanatophoric Dysplasia, Types 1 & 2 (FGFR3) 13 Mutations, Fetal : ARUP Lab Tests

Home | Contact | Careers | ARUP Connect™ Login | ARUP Events

Laboratory Test Directory

Test Directory | Entire Site

Search Tips

Wildcards Symbol (*)

The wildcard symbol (*) can be used in place of letters or characters in query words to search for different permutations of a word.

*	Can be in any position in the term and matches any number of characters.
Examples:	hemo*	matches hemolytic, hemophilia and hemophilia
	*NA	matches DNA and RNA
	*tet**	matches text and test
	BCL*	matches bcl-1/JH and bcl-2/JH
	virus*	matches virus or viruses
	*glucan*	matches beta-1,3-d-Glucan

Boolean Parameters

Search terms can be a single word or several words. The search engine automatically inserts and between words if nothing else is specified, so the Boolean term and can be omitted in search terms. For example, searching for tissue assay is the same as searching for tissue AND assay.

Quotes can be used to search for phrases. For example:

"tissue assay "

Words must be present in the specified order with no intervening words

The following boolean connectors can be used: AND, OR, NOT Examples:

tissue AND assay	Both words must be present
tissue OR assay	Either word can be present
assay NOT tissue	Only assay can be present, tissue cannot appear on the page

Testing Information

Testing Specialties

Specimen Handling

Client Services

Lab Expertise

Utilization Management

Research & Development

Education

About ARUP

ARUP's Laboratory Test Directory

Thanatophoric Dysplasia, Types 1 & 2 (FGFR3) 13 Mutations, Fetal : 0051508

Time Sensitive

Patient History for Fetal Molecular Testing

Mnemonic: TD PAN FE

Methodology:	Polymerase Chain Reaction/Fragment Analysis
Performed:	Sun-Sat
Reported:	3-7 days
Specimen Required:	Collect: Fetal Specimen: Two T-25 flasks at 80% confluent of cultured amniocytes. If the client is unable to culture amniocytes, this can be arranged by contacting ARUP Client Services at (800) 522-2787. Maternal Specimen: Lavender (EDTA), pink (K₂EDTA), or yellow (ACD Solution A or B). Specimen Preparation: Cultured amniocytes: Fill flasks with culture media. Transport two T-25 flasks at 80% confluent of cultured amniocytes. Backup cultures must be retained at the client's institution until testing is complete. Maternal Specimen: Transport 3 mL whole blood. Storage/Transport Temperature: Cultured amniocytes: CRITICAL ROOM TEMPERATURE. Must be received within 48 hours of shipment due to lability of cells. Maternal Specimen: Room temperature. Ship with the fetal specimen. Remarks: Maternal sample is recommended for proper test interpretation; order Maternal Cell Contamination. Patient History Form is available on the ARUP Web site or by contacting ARUP Client Services. Stability (collection to initiation of testing): Fetal: Ambient: 48 hours; Refrigerated: Unacceptable; Frozen: Unacceptable Maternal: Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data:	Background information for Thanatophoric Dysplasia, Types 1 and 2 (FGFR3) 13 Mutations, Fetal Characteristics: Micromelia, macrocephaly, short ribs and a narrow thorax; TD I has bowed femurs and TD II has straight femurs and a cloverleaf skull; death usually occurs from respiratory insufficiency within hours or days of birth. Incidence: 1 in 20,000 to 50,000 births. Inheritance: Autosomal dominant; arising from a de novo mutation. Cause: Fibroblast growth factor receptor 3 (FGFR3) gene mutations. Mutations tested: c.742C>T (R248C), c.746C>G (S249C), c.1108G>T (G370C), c.1111A>T (S371C), c.1118A>G (Y373C), c.2419T>G (X807G), c.2419T>A (X807R), c.2420G>T (X807L), c.2420G>C (X807S), c.2421A>T (X807C), c.2421A>C (X807C) and c.2421A>G (X807W) for TD I and c.1948A>G (K650E) for TD II. Clinical Sensitivity and Specificity: 99 percent. Methodology: Polymerase chain reaction (PCR) and single nucleotide extension followed by capillary electrophoresis. Analytic Specificity and Sensitivity: 99 percent. Limitations: Mutations other than those targeted in FGFR3 will not be detected; analytic sensitivity may be compromised by rare primer site mutations. For quality assurance purposes, ARUP Laboratories will confirm the above result at no charge following delivery. Order Confirmation of Fetal Testing and include a copy of the original fetal report (or the mother's name and date of birth) with the test submission. Please contact an ARUP genetic counselor at (800) 242-2787 extension 2141 prior to specimen submission. This test is performed pursuant to an agreement with Roche Molecular Systems, Inc. Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com. Refer to Statement C under Testing Information at http://www.aruplab.com.
CPT Code(s):	83891 Isolation; 83900 Multiplex amplification; 83901 x2 Additional amplification; 83914 x9 Extension; 83909 Capillary electrophoresis; 83912 Interpretation and report. FCC: 83900 Multiplex amplification; 83901 x14 Additional amplification; 83909 Capillary electrophoresis. For MCC Maternal cell (0050608) add: 83891 Isolation; 83900 Multiplex amplification; 83901 x14 Additional amplification; 83909 Capillary electrophoresis; 83912 Interpretation and report - Additional CPT Codes may be required for procedures performed to test for oncologic or inherited disorders.
Cross References:	TD (Thanatophoric Dysplasia, Types 1 & 2 (FGFR3) 13 Mutations, Fetal)

All ARUP Sites: www.aruplab.com · www.arupconsult.com · www.arup.utah.edu · www.childx.org · www.utahblood.org